Hutch News
Results per Page:
New Science Spotlight Articles
Every month, Fred Hutch postdoc writer/editors summarize two papers from each of our scientific divisions to stimulate collaborations across campus
September 18, 2023
Dr. Sita Kugel receives V Foundation Translational Research Award
Grant makes possible a clinical trial of targeted treatment for pancreatic cancer
Functionalizing the genome to find novel pancreatic cancer treatments
From the Kemp Lab, Human Biology Division
Overcoming exhaustion: Engineered T-cells and pancreas cancer
From the Greenberg Lab, Clinical Research Division, Fred Hutch and the Stromnes Lab, University of Minnesota
Science Says: Fearless science
Immunotherapy, equity in colorectal cancer and the latest on the COVID-19 virus's omicron variant
Seeking targeted treatments for pancreatic cancer
American Cancer Society fellowship to Dr. Nithya Kartha supports search for vulnerabilities in most aggressive pancreatic tumor subtype
Fred Hutch Evergreen Fund awards six grants to promising projects
Scientists receive up to $200K to boost research for projects deemed to have partnership potential
3 cancers, 2 women, 1 goal
A patient and caregiver bond over their shared diagnosis, lust for adventure and quest to cure the ‘harder cancers’
Dr. Sita Kugel receives grant to study aggressive form of pancreatic cancer
A new type of NCI award will allow her to pursue novel therapeutic avenues
Cancer prevention community mourns epidemiologist Dr. Alan Kristal
Pioneering researcher studied how diet can lower cancer risk
Dr. Heather Wright receives NIH training fellowship to study pancreatic cancer metastasis
She will explore the role of a molecule called hyaluronan in promoting cancer spread
Dr. Sita Kugel named 2018 V Scholar
Pancreatic cancer researcher will focus on development of targeted therapeutics
5 questions with a cancer immunotherapy expert
Dr. Phil Greenberg to receive high honor for his contributions to the field
Lyani Valle: leukemia survivor, Obliteride walker
'Cancer was a huge wake-up call to what is important in life'
Immunotherapy strategy for ovarian cancer aims to rewire a ‘kill switch’ to ramp-up signal
T cells bearing a new engineered protein boost immunotherapy’s effectiveness in laboratory models of AML, ovarian, pancreatic cancers